Literature DB >> 17227628

The protective action of scutellarin against immunological liver injury induced by concanavalin A and its effect on pro-inflammatory cytokines in mice.

Zheng Huai Tan1, Ling Hong Yu, Huai Lin Wei, Geng Tao Liu.   

Abstract

Scutellarin is a natural compound from a Chinese herb. The purpose of this paper was to study the protective effect of scutellarin on concanavalin A (Con A)-induced immunological liver injury and its effect on liver nuclear factor kappaB (NF-kappaB), tumor necrosis factor alpha (TNF-alpha), interferon gamma (IFN-gamma), and inducible nitric oxide synthase (iNOS) expression in mice. Mouse liver injury was produced by injection of Con A 25 mg kg-1 via the tail vein. Scutellarin 50 or 100 mg kg-1 was peritoneally administered to mice 9 or 1 h before injection of Con A. The levels of serum alanine aminotransferase (ALT) and asparatate aminotransferase (AST), NO2-/NO3- and TNF-alpha were determined with biochemical kits, and ELISA using Quantikine Mouse TNF-alpha kit according the manufacturer's instructions. Liver lesions were examined by light microscope. The expression of TNF-alpha, IFN-gamma, iNOS and Fas mRNA in the livers was detected by RT-PCR; and the expression of c-Fos, c-Jun, iNOS and IkappaB proteins was measured by Western Blotting. As a result, pretreatment with scutellarin 100 mg kg-1 significantly decreased the serum ALT, AST, NO2-/NO3- and TNF-alpha levels, and also reduced liver lesions induced by Con A. Scutellarin 100 mg kg-1 down-regulated expression of TNF-alpha and iNOS mRNA, and c-Fos, c-Jun and iNOS protein, while scutellarin enhanced the degradation of IkappaB in the livers of mice injected with Con A. The results suggest that scutellarin has a protective action against Con A-induced liver injury in mice, and its active mechanism may be related to the inhibition of the NF-kappaB-TNF-alpha-iNOS transduction pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17227628     DOI: 10.1211/jpp.59.1.0015

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  5 in total

1.  Metabolic and pharmacokinetic studies of scutellarin in rat plasma, urine, and feces.

Authors:  Jian-feng Xing; Hai-sheng You; Ya-lin Dong; Jun Lu; Si-ying Chen; Hui-fang Zhu; Qian Dong; Mao-yi Wang; Wei-hua Dong
Journal:  Acta Pharmacol Sin       Date:  2011-04-25       Impact factor: 6.150

2.  Research on scutellarin parenteral solution's protective effects in rats with severe acute pancreatitis and multiple organ injuries.

Authors:  Chen Hanqing; Zhang Xiping; Ou Jingmin; Jiang Jun; Wu Dijiong
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

Review 3.  The Pharmacological Targets and Clinical Evidence of Natural Products With Anti-hepatic Inflammatory Properties.

Authors:  Jinghua Peng
Journal:  Front Pharmacol       Date:  2018-06-05       Impact factor: 5.810

Review 4.  Summary of Natural Products Ameliorate Concanavalin A-Induced Liver Injury: Structures, Sources, Pharmacological Effects, and Mechanisms of Action.

Authors:  Sabrin R M Ibrahim; Alaa Sirwi; Basma G Eid; Shaimaa G A Mohamed; Gamal A Mohamed
Journal:  Plants (Basel)       Date:  2021-01-25

5.  Scutellarein Reduces Inflammatory Responses by Inhibiting Src Kinase Activity.

Authors:  Nak Yoon Sung; Mi-Yeon Kim; Jae Youl Cho
Journal:  Korean J Physiol Pharmacol       Date:  2015-08-20       Impact factor: 2.016

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.